-
公开(公告)号:US11351271B2
公开(公告)日:2022-06-07
申请号:US15509258
申请日:2015-09-08
发明人: Ron Weiss , Liliana Wroblewska , Velia Siciliano , Tasuku Kitada , Maria Hottelet Foley , Katie Bodner , Hirohide Saito , Kei Endo , Darrell J. Irvine , Tyler Wagner , Jacob Becraft
摘要: Engineered synthetic RNA-based genetic circuits are provided that are regulated exclusively at the post-transcriptional level.
-
公开(公告)号:US20220395585A1
公开(公告)日:2022-12-15
申请号:US17735627
申请日:2022-05-03
发明人: Ron Weiss , Liliana Wroblewska , Velia Siciliano , Tasuku Kitada , Maria Hottelet Foley , Katie Bodner , Hirohide Saito , Kei Endo , Darrell J. Irvine , Tyler Wagner , Jacob Becraft
摘要: Engineered synthetic RNA-based genetic circuits are provided that are regulated exclusively at the post-transcriptional level.
-
公开(公告)号:US11235051B2
公开(公告)日:2022-02-01
申请号:US16634205
申请日:2018-07-27
发明人: Ronald Vogels , Marijn Van Der Neut Kolfschoten , Darrell J. Irvine , Ron Weiss , Ely Blanton Porter , Mariane Bandeira Melo , Tasuku Kitada
IPC分类号: A61K48/00 , A61K9/127 , C07K14/535 , C12N15/85 , A61K31/7115 , A61K39/12 , C12N15/86 , A61K39/00
摘要: Compositions and methods are described for inducing an immune response against an immunogen in humans. The induced immune response is obtained by administering a heterologous prime-boost combination of an in vitro transcribed (IVT) self-replicating RNA (repRNA) and an adenovirus vector. The compositions and methods can be used to provide a protective immunity against a disease, such as a viral infection or a cancer, in humans.
-
公开(公告)号:US11964007B2
公开(公告)日:2024-04-23
申请号:US17645556
申请日:2021-12-22
发明人: Ronald Vogels , Marijn Van Der Neut Kolfschoten , Darrell J. Irvine , Ron Weiss , Ely Blanton Porter , Mariane Bandeira Melo , Tasuku Kitada
CPC分类号: A61K39/12 , C12N15/86 , A61K2039/53 , A61K2039/545 , C12N2760/18534
摘要: Compositions and methods are described for inducing an immune response against an immunogen in humans. The induced immune response is obtained by administering a heterologous prime-boost combination of an in vitro transcribed (IVT) self-replicating RNA (repRNA) and an adenovirus vector. The compositions and methods can be used to provide a protective immunity against a disease, such as a viral infection or a cancer, in humans.
-
公开(公告)号:US20220111033A1
公开(公告)日:2022-04-14
申请号:US17645556
申请日:2021-12-22
发明人: Ronald Vogels , Marijn Van Der Neut Kolfschoten , Darrell Irvine , Ron Weiss , Ely Porter , Mariane Bandeira Melo , Tasuku Kitada
摘要: Compositions and methods are described for inducing an immune response against an immunogen in humans. The induced immune response is obtained by administering a heterologous prime-boost combination of an in vitro transcribed (IVT) self-replicating RNA (repRNA) and an adenovirus vector. The compositions and methods can be used to provide a protective immunity against a disease, such as a viral infection or a cancer, in humans.
-
公开(公告)号:US20180296702A1
公开(公告)日:2018-10-18
申请号:US15509258
申请日:2015-09-08
发明人: Ron Weiss , Liliana Wroblewska , Velia Siciliano , Tasuku Kitada , Maria Hottelet Foley , Katie Bodner , Hirohide Saito , Kei Endo , Darrell J. Irvine , Tyler Wagner , Jacob Becraft
CPC分类号: A61K48/0066 , C12N15/10 , C12N15/63 , C12N15/85 , C12N2840/102
摘要: Engineered synthetic RNA-based genetic circuits are provided that are regulated exclusively at the post-transcriptional level.
-
公开(公告)号:US11026894B2
公开(公告)日:2021-06-08
申请号:US16739197
申请日:2020-01-10
发明人: Darrell J. Irvine , Ron Weiss , Tasuku Kitada , Mariane Melo , Yuan Zhang
摘要: Disclosed herein are lipid nanoparticles comprising 1,2-dioleoyl-3-trimethylammonium propane (DOTAP), 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), cholesterol, and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000](DSPE-PEG2000), compositions including such lipid nanoparticles, and methods of treatment using such lipid nanoparticles and compositions.
-
公开(公告)号:US20200222332A1
公开(公告)日:2020-07-16
申请号:US16739197
申请日:2020-01-10
发明人: Darrell J. Irvine , Ron Weiss , Tasuku Kitada , Mariane Melo , Yuan Zhang
摘要: Disclosed herein are lipid nanoparticles having a specific composition, compositions including such lipid nanoparticles, and methods of treatment using such lipid nanoparticles and compositions.
-
-
-
-
-
-
-